Maquet launches pressure control syringe for CABG
Maquet Cardiovascular has launched its Vasoshield pressure controlling syringe that limits “flushing” pressure and controls vessel distension to maintain internal vessel reliability during CABG.

According to the Wayne, N.J.-based company, if pressure is not controlled it has the potential to reach levels of 600 mm Hg, which could create damage to the internal vessel surface.

The Vasoshield syringe has three settings—150, 250 or 350 mm Hg—and pressure can be pre-set in increments for flow delivery during vein preparation, Maquet said.

The company said that the technology is part of the Vasoview product portfolio and is being demonstrated at the American Association of Thoracic Surgeons (AATS) annual meeting May 1-5 in Toronto.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup